2017-2022

University research. 2 prototypes tested on 100+ patients. 1m EUR invested.

2022

Buildit accelerator Batch15 graduated. Idea validated.

February 2023

Obtained exclusive IP licence. Spinoff created.

May 2023

Joined Health Founders accelerator Batch IV.

January 2024

Secured first investment of 50 000 EUR from Commercialization Reactor.

July 2024

Received 60’000 EUR R&D cascade funding grant.

July 2024

The first international demo on real patients (France).

July 2024

Accepted to Startupbootcamp Class 2024.

August 2024

EIT Health Innostars Awards finalist.